ID: ALA253020

Max Phase: Preclinical

Molecular Formula: C25H38N4O6S

Molecular Weight: 522.67

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1ccccc1C1CCN(S(=O)(=O)CC2(C(=O)NO)CCN(C(=O)OC[C@H]3CCCN3)CC2)CC1

Standard InChI:  InChI=1S/C25H38N4O6S/c1-19-5-2-3-7-22(19)20-8-13-29(14-9-20)36(33,34)18-25(23(30)27-32)10-15-28(16-11-25)24(31)35-17-21-6-4-12-26-21/h2-3,5,7,20-21,26,32H,4,6,8-18H2,1H3,(H,27,30)/t21-/m1/s1

Standard InChI Key:  IKHATIJQVUIUCY-OAQYLSRUSA-N

Associated Targets(Human)

ADAM10 375 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Matrix metalloproteinase-2 6627 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Matrix metalloproteinase-1 7046 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Liver microsomes 16955 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 522.67Molecular Weight (Monoisotopic): 522.2512AlogP: 1.98#Rotatable Bonds: 7
Polar Surface Area: 128.28Molecular Species: BASEHBA: 7HBD: 3
#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 3#RO5 Violations (Lipinski): 1
CX Acidic pKa: 8.81CX Basic pKa: 10.31CX LogP: -0.18CX LogD: -1.36
Aromatic Rings: 1Heavy Atoms: 36QED Weighted: 0.37Np Likeness Score: -0.67

References

1. Burns DM, He C, Li Y, Scherle P, Liu X, Marando CA, Covington MB, Yang G, Pan M, Turner S, Fridman JS, Hollis G, Vaddi K, Yeleswaram S, Newton R, Friedman S, Metcalf B, Yao W..  (2008)  Conversion of an MMP-potent scaffold to an MMP-selective HER-2 sheddase inhibitor via scaffold hybridization and subtle P1' permutations.,  18  (2): [PMID:18068976] [10.1016/j.bmcl.2007.11.086]

Source